FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Aurobindo Pharma Sulfamethoxazole and Trimethoprim Tablets Recall

Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tabl…

Aurobindo Pharma USA Inc. · East Windsor, NJ

Risk level
Class II
Reported by FDA
Sep 2, 2020
Recall ID
D-1535-2020
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Sulfamethoxazole and Trimethoprim Tablets starting Aug 10, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1535-2020 on Sep 2, 2020. Reason: Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s). Status: Terminated.

Why it was recalled

Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).

Product description

Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC: 65862-420-05.

Lot numbers, UPCs & expiration codes

Lot #s: STSD19109-A, Exp. 05/31/2022; SP1D19083AA3, SP1D19084AA3, Exp. 08/31/2022.

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1535-2020
Classification
Class II
Status
Terminated
Recall initiated
Aug 10, 2020
FDA report date
Sep 2, 2020
Quantity
5748 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc.

Original FDA data

Every field from FDA enforcement report D-1535-2020, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
86190
Address
279 Princeton Hightstown Rd
Code information
Lot #s: STSD19109-A, Exp. 05/31/2022; SP1D19083AA3, SP1D19084AA3, Exp. 08/31/2022.
Postal code
08520-1401
Report date
Sep 2, 2020
Product type
Drugs
Recall number
D-1535-2020
Classification
Class II
Recalling firm
Aurobindo Pharma USA Inc.
Product quantity
5748 bottles
Termination date
Jun 28, 2024
Reason for recall
Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC: 65862-420-05.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Aug 10, 2020
Initial firm notification
Letter
Center classification date
Aug 21, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1535-2020, published Sep 2, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls